参考文献/References:
[1] Tsao CW,Aday AW,Almarzooq ZI,et al. Heart disease and stroke statistics-2022 update:a report from the American Heart Association[J]. Circulation,2022,145(8):e153-e639.
[2] Guo J,Wang H,Li Y,et al. Nanotechnology in coronary heart disease[J]. Acta Biomater,2023, 171:37-67.
[3] Mann J,Williams M,Wilson J,et al. Exercise-induced myocardial dysfunction detected by cardiopulmonary exercise testing is associated with increased risk of mortality in major oncological colorectal surgery[J]. Br J Anaesth,2020, 124(4):473-479.
[4] Zhu SY,Wang X,Sun XG. [Clinical study on the diagnostic value of cardiopulmonary exercise test for coronary atherosclerotic heart disease][J]. Zhongguo Ying Yong Sheng Li Xue Za Zhi,2021,37(1):72-78.
[5] Chaudhry S,Arena R,Bhatt DL,et al. A practical clinical approach to utilize cardiopulmonary exercise testing in the evaluation and management of coronary artery disease:a primer for cardiologists[J]. Curr Opin Cardiol,2018,33(2):168-177.
[6] Belardinelli R,Lacalaprice F,Tiano L,et al. Cardiopulmonary exercise testing is more accurate than ECG-stress testing in diagnosing myocardial ischemia in subjects with chest pain[J]. Int J Cardiol,2014,174(2):337-342.
[7] Popovic D,Guazzi M,Jakovljevic DG,et al. Quantification of coronary artery disease using different modalities of cardiopulmonary exercise testing[J]. Int J Cardiol,2019,285:11-13.
[8] Liu W,Liu X,Liu T,et al. The value of cardiopulmonary exercise testing in predicting the severity of coronary artery disease[J]. J Clin Med,2022,11(14):4170.
[9] de Lorenzo A,da Silva CL,Souza FCC,et al. Clinical,scintigraphic,and angiographic predictors of oxygen pulse abnormality in patients undergoing cardiopulmonary exercise testing[J]. Clin Cardiol,2017,40(10):914-918.
[10] Popovic D,Martic D,Djordjevic T,et al. Oxygen consumption and carbon-dioxide recovery kinetics in the prediction of coronary artery disease severity and outcome[J]. Int J Cardiol,2017,248:39-45.
[11] 张欣颖,蔡鹤. 急性期心脏康复对PCI术后患者运动耐量的影响[J]. 长春中医药大学学报,2018,34(4):776-778.
[12] Zegkos T,Kamperidis V,Ntelios D,et al. Left atrial myopathy is associated with exercise incapacity and ventilatory inefficiency in hypertrophic cardiomyopathy[J]. Heart Lung Circ,2023,32(2):215-223.
[13] Cassar MP,Tunnicliffe EM,Petousi N,et al. Symptom persistence despite improvement in cardiopulmonary health—Insights from longitudinal CMR,CPET and lung function testing post-COVID-19[J]. EClinicalMedicine,2021,41:101159.
[14] Grucha?a-Niedoszytko M,Niedoszytko P,Kaczkan M,et al. Cardiopulmonary exercise test and bioimpedance as prediction tools to predict the outcomes of obesity treatment[J]. Pol Arch Intern Med,2019,129(4):225-233.
[15] 赵琳,王静. 心肺运动试验与冠心病患者病情程度及预后的相关性分析[J]. 中国民康医学,2022,34(9):8-10,14.
[16] 李丹,沈涛,赵威,等. 心肺运动试验摄氧量恢复延迟对经皮冠状动脉介入治疗术后患者预后的影响[J]. 中国介入心脏病学杂志,2022,30(2):107-112.
[17] Kurpaska M,Krzesiński P,Gielerak G,et al. Cardiopulmonary exercise testing and impedance cardiography in the assessment of exercise capacity of patients with coronary artery disease early after myocardial revascularization[J]. BMC Sports Sci Med Rehabil,2022,14(1):134.
[18] Kunutsor SK,Kurl S,Khan H,et al. Associations of cardiovascular and all-cause mortality events with oxygen uptake at ventilatory threshold[J]. Int J Cardiol,2017,236:444-450.
[19] Laukkanen JA,Araújo CGS,kurl S,et al. Relative peak exercise oxygen pulse is related to sudden cardiac death,cardiovascular and all-cause mortality in middle-aged men[J]. Eur J Prev Cardiol,2018,25(7):772-782.
[20] 韩彬. 心肺运动试验指导下的运动康复对改善冠心病患者心肺功能的效果分析[J]. 中国实用医药,2023,18(16):143-146.
[21] Swardfager W,Herrmann N,Dowlati Y,et al. Relationship between cardiopulmonary fitness and depressive symptoms in cardiac rehabilitation patients with coronary artery disease[J]. J Rehabil Med,2008,40(3):213-218.
[22] Dibben GO,Faulkner J,Oldridge N,et al. Exercise-based cardiac rehabilitation for coronary heart disease:a meta-analysis[J]. Eur Heart J,2023,44(6):452-469.
[23] Sunamura M,ter Hoeve N,van den Berg-Emons RJG,et al. Cardiac rehabilitation in patients with acute coronary syndrome with primary percutaneous coronary intervention is associated with improved 10-year survival[J]. Eur Heart J Qual Care Clin Outcomes,2018,4(3):168-172.
相似文献/References:
[1]杜钧,佘强.冠心病抗炎治疗的临床研究进展[J].心血管病学进展,2016,(1):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
DU Jun,SHE Qiang.Clinical Research Progress of Anti-inflammatory Therapy of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2016,(6):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
[2]努热曼古丽·阿布都克热木,马依彤.重度左心室收缩功能不全的冠心病患者血运重建治疗疗效及预后的评价[J].心血管病学进展,2016,(1):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
NUREMANGULI·Abudukeremu,MA Yitong.Evaluation of Efficacy and Prognosis of Revascularization Therapy on Patients
with Coronary Heart Disease and Severe Left Ventricular Systolic Dysfunction[J].Advances in Cardiovascular Diseases,2016,(6):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
[3]刘洋,综述,伍贵富,等.增强型体外反搏治疗冠心病的新机制[J].心血管病学进展,2016,(2):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
LIU Yang,WU Guifu.New Mechanism of Enhanced External Counterpulsation for
Treatment of Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2016,(6):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
[4]杨洋,综述,沈比先,等.心脏核磁共振评估缺血性心脏病的应用价值[J].心血管病学进展,2016,(2):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
YANG Yang,SHEN Bixian.Value of Cardiac Magnetic Resonance Assessment of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(6):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
[5]史敬,综述,马依彤,等.n-3多不饱和脂肪酸对心血管疾病的临床应用[J].心血管病学进展,2016,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
SHI Jing,MA Yitong.Effects of n-3 Polyunsaturated Fatty Acids on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(6):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
[6]高柳,袁晋青.重复支架置入术治疗药物洗脱支架再狭窄的研究进展[J].心血管病学进展,2015,(5):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
GAO Liu,YUAN Jingqing.Progress in Treatment for Drug-eluting Stent Restenosis by
Re-implementation of Stents[J].Advances in Cardiovascular Diseases,2015,(6):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
[7]邓文政,邓平.MG53蛋白的研究进展[J].心血管病学进展,2015,(5):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
DENG Wenzheng,DENG Ping.Research Progress of MG53[J].Advances in Cardiovascular Diseases,2015,(6):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
[8]陈静,李兴德.冠心病患者服药依从性的研究进展[J].心血管病学进展,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
CHEN Jing,LI Xingde.Advances in Medication Adherence of Patients with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
[9]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
[10]郭彩艳 靳春荣.腺苷药物在心血管疾病诊治中的应用进展[J].心血管病学进展,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
GUO CaiyanJIN Chunrong.Progress in the Application of Adenosine Drugs in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(6):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
[11]蒋昭隆刘剑雄.心肺运动试验在冠心病运用现状[J].心血管病学进展,2019,(9):1290.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.027]
JIANG Zhaolong,LIU Jianxiong.Current Status of Cardiopulmonary Exercise Test in Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(6):1290.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.027]